Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Sell
46
ADPT Quote, Financials, Valuation and Earnings
Last price:
$7.93
Seasonality move
:
14.52%
Day range:
$7.38 - $8.30
52-week range:
$2.28 - $9.01
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.53x
P/B ratio:
5.82x
Volume:
4.1M
Avg. volume:
2.4M
1-year change:
203.05%
Market cap:
$1.2B
Revenue:
$179M
EPS (TTM):
-$1.09
Earnings Data
Next earnings date for ADPT
May 07
2025
Most recent earnings per share
-$0.23
Beat by $0.01
(Feb 11/2025)
Consensus Estimate
-$0.24
(Feb 11/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ADPT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $47.3M | -- | -- | -$0.25 | -- |
| 05/07/2025 | Q1 | $42.1M | -- | -- | -$0.31 | -- |
| 02/11/2025 | Q4 | $46M | $47.5M | -$0.23 | -$0.24 | $0.01 |
| 11/07/2024 | Q3 | $40.2M | $46.4M | -$0.22 | -$0.27 | $0.05 |
| 08/01/2024 | Q2 | $39.4M | $43.2M | -$0.31 | -$0.33 | $0.02 |
| 05/07/2024 | Q1 | $38.8M | $41.9M | -$0.33 | -$0.34 | $0.01 |
| 02/14/2024 | Q4 | $48.5M | $45.8M | -$0.48 | -$0.33 | -$0.15 |
| 11/09/2023 | Q3 | -- | -- | -$0.35 | -$0.34 | -$0.01 |
| 08/02/2023 | Q2 | -- | -- | -$0.33 | -$0.35 | $0.02 |
| 05/03/2023 | Q1 | -- | -- | -$0.40 | -$0.37 | -$0.03 |
| 02/14/2023 | Q4 | -- | -- | -$0.28 | -$0.35 | $0.07 |
| 11/03/2022 | Q3 | -- | -- | -$0.32 | -$0.38 | $0.06 |
| 08/03/2022 | Q2 | -- | -- | -$0.37 | -$0.43 | $0.06 |
| 05/04/2022 | Q1 | -- | -- | -$0.44 | -$0.45 | $0.01 |
| 02/15/2022 | Q4 | -- | -- | -$0.43 | -$0.45 | $0.02 |
| 11/03/2021 | Q3 | -- | -- | -$0.40 | -$0.43 | $0.03 |
| 08/04/2021 | Q2 | -- | -- | -$0.35 | -$0.41 | $0.06 |
| 05/05/2021 | Q1 | -- | -- | -$0.29 | -$0.40 | $0.11 |
| 02/24/2021 | Q4 | -- | -- | -$0.33 | -- | -- |
| 11/10/2020 | Q3 | -- | -- | -$0.27 | -- | -- |
| 08/10/2020 | Q2 | -- | -- | -$0.26 | -- | -- |
| 05/12/2020 | Q1 | -- | -- | -$0.25 | -- | -- |
| 02/26/2020 | Q4 | -- | -- | -$0.17 | -- | -- |
| 11/12/2019 | Q3 | -- | -- | -$0.11 | -- | -- |
| 08/13/2019 | Q2 | -- | -- | -$1.23 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.15 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.12 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$0.08 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$0.12 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.12 | -- | -- |
| 03/22/2017 | Q4 | -- | -- | -- | $0.22 | -- |
| 11/01/2016 | Q3 | -- | -- | -- | $0.46 | -- |
| 07/21/2016 | Q2 | -- | -- | $0.43 | $0.48 | -$0.05 |
| 04/20/2016 | Q1 | -- | -- | $0.41 | $0.37 | $0.04 |
| 02/24/2016 | Q4 | -- | -- | $0.41 | $0.48 | -$0.07 |
| 10/22/2015 | Q3 | -- | -- | $0.27 | $0.31 | -$0.04 |
| 07/23/2015 | Q2 | -- | -- | $0.38 | $0.09 | $0.29 |
Adaptive Biotechnologies Earnings Questions
-
How Much did Adaptive Biotechnologies Generate in Revenue Last Quarter?
Adaptive Biotechnologies reported $47.5M worth of top line sales in its most recent quarter.
-
Did Adaptive Biotechnologies Beat Earnings Last Quarter?
Adaptive Biotechnologies announced earnings per share of -$0.23 which represents a beat of analyst forecast a -$0.24 per share.
-
Is Adaptive Biotechnologies Profitable?
Adaptive Biotechnologies reported $29.4M that represents $0.20 per share over the last quarter.
-
What is the Analyst Consensus for Adaptive Biotechnologies EPS Next Year?
Adaptive Biotechnologies's earnings are forecast to decrease from -$1.08 per share to -$0.91 per share next year representing a decrease of -15.28%.
-
When is Adaptive Biotechnologies's Earnings Date?
Adaptive Biotechnologies's next earnings date is May 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
